UK GMP Manufactured · 260-Volunteer Human Study · Launching in 2026
T-Booster
News & media

Science, clinical progressand public visibility

T-Booster has received national television, press and online attention while the team progresses final analysis and commercial preparation.

DBC NewsDBC News30-minute health and sciencediscussion on national TV.
ETVETVPrime-time national reporton the research programme.
The Daily StarThe Daily StarNational press featureon the science and vision.
Public visibilityGrowing public awarenessbefore commercial launch.
Media momentum

Public credibility beforecommercial launch

Coverage helps explain the science, demonstrate execution and create awareness for consumer and partnership conversations.

DBC News

National TV health discussion

The interview introducedthymus biology, immune ageingand the clinical-study story.

Watch →
ETV

Research coverage

The prime-time report coveredthe programme significanceand aired multiple times.

Watch →
The Daily Star

Immunity research feature

Dr Arif Sheikh presentedthe thymus-focused scienceand development approach.

Read →
Development update

What the team isworking on now

The most important public updates will relate to final laboratory interpretation, publication, IP, production and launch readiness.

Science

Laboratory analysis

Complete endpoint tables,age-group analysis andstatistical interpretation.

Publication

Scientific manuscript

Prepare a transparentscientific manuscript forcommunication and peer review.

IP

Patent and trademark

Protect formulation know-how,the brand and associatedcommercial rights.

Launch

Market preparation

Prepare production, compliance,distribution andevidence-led marketing.

Media resources

A clear story forjournalists and partners

Media enquiries can request a company backgrounder, founder biography, study synopsis, product images and broadcast material.

Suggested interview themes

THYMUS BIOLOGYHEALTHY IMMUNE AGEINGSUPPLEMENT INNOVATIONCLINICAL RESEARCH

Responsible communication

Public discussion should distinguish preliminary findings from final results and avoid disease-treatment or age-reversal claims.

Media contact

Request interviews, visualsor a company backgrounder

Use the contact form and select “Media enquiry”.

Contact the media team